Press Releases | Thermo Fisher Newsroom (Research & Development) MediaRoom New Study Confirms High Technical Comparability of Different BRAHMS PCT Assays at all Clinical Cut-offs for Various Clinical Settings Analysis shows that high quality BRAHMS PCT (procalcitonin) assays are reliable tools to assist in the safe management of patients with suspected bacterial infection and sepsis Tue, 05 Sep 2017 08:00:00 -0400 First FDA-Approved Cell Therapy for Leukemia Utilizes Thermo Fisher Scientific's CTS Dynabeads Technology Kymriah™ (tisagenlecleucel, formerly CTL019), the first FDA-approved CAR-T cell therapy, uses CTS Dynabeads CD3/CD28 spherical beads to isolate, activate and expand T cells Wed, 30 Aug 2017 14:57:00 -0400 Multi-Center Clinical Study Confirms Decreased Levels of Procalcitonin as an Independent Predictor of Mortality in Patients with Severe Sepsis and Septic Shock Results from Procalcitonin MOnitoring SEpsis Study published in May 2017 issue of Critical Care Medicine Thu, 20 Apr 2017 09:04:00 -0400 New Research Innovations in Liquid Biopsy, Bioinformatics and Liquid Handling Advance Future of Precision Medicine Broad spectrum of technological advances for cancer research on display at AACR 2017 Thu, 30 Mar 2017 08:00:00 -0400 New Comprehensive Carrier Screening Research Assay Features Richest Pan-Ethnic Panel for Detection of Multiple Genetic Variations in Inherited Disease CarrierScan™ Assay from Thermo Fisher Scientific consolidates conventional multi-assay approach for “all-in-one” research Tue, 21 Mar 2017 08:00:00 -0400